English

Research and Development

SSI is one of Denmark’s largest research institutions in the health sector.
More about SSI's research and development

R and DSSI is one of Denmark’s largest research institutions in the health sector
Contract ServicesSSI provides contract work within our core activities and competences
Job and CareerRead about SSI as a workplace and meet some of our employees
EPI-NEWSNational surveillance of communicable diseases
Girl in the rain

New mission and strategy

SSI has produced a new strategy with a focus on infectious disease preparedness, biobanking and biomarkers, and research. Read more about SSI's new strategy...
Danish National Biobank

The Danish National Biobank

The Danish National Biobank gives scientists from Denmark and abroad overview and access to more than 16 million biological samples in both existing and future collections. Read more about the Danish National Biobank...
The European pertussis meeting will be held at SSI in September 2018
08-05-2018
For the third time, SSI will host the annual European pertussis meeting, EUPertstrain/EUPertgenomics.
Confidence regained. Childhood vaccination is once again a popular offer
25-04-2018
In 2017, the coverage of all vaccines in the childhood vaccination programme rose. For several vaccines, the increase was quite...
Whooping cough returned to its normal level in 2017
25-04-2018
Whooping cough still occurs, particularly among small children, unvaccinated infants and older school children. Furthermore, th...

More news...

EPI-NEWS, No 22 - 2018
Syphilis 2017
EPI-NEWS, No 21 - 2018
HAIBA 2017
EPI-NEWS, No 18-20 - 2018
Blood donor screening 2017
EPI-NEWS, No 17 - 2018
Annual report on the Danish childhood vaccination programme
EPI-NEWS, No 16 - 2018
Laboratory-confirmed whooping cough 2017

More EPI-NEWS...

SSI receives EUR 13.8 million grant from EDCTP to test new tuberculosis (TB) vaccine
21-03-2018
Statens Serum Institut (SSI) in Copenhagen Denmark has been granted a sum of EUR 13.8 million from the European & Developing Countries Cl...
Scientist at SSI receives a grant for further development of a vaccine against resistant enteropathogen
22-12-2017
Scientists at SSI have developed a new potential vaccine against infections from the enteropathogen, Clostridium difficile (CD).
Sweden and Finland are more successful in the fight against tuberculosis than Denmark
09-11-2017
The number of tuberculosis cases among Swedish and Finnish indigenous citizens falls faster than in Denmark shows a new Nordic survey.
Increase in hospital admissions for infections following simultaneous vaccination with MMR and DTaP-IPV-Hib among Danish children
14-11-2016
New research from CVIVA shows that Danish children, who have received the live MMR vaccine together with the non-live DTaP-IPV-Hib vaccin...

More R and D News...

Available Positions:

Currently, we have no available positions.

Statens Serum Institut         

5 Artillerivej

DK 2300 Copenhagen S

T  +45 3268 3268

F  +45 3268 3868